Signal transducer and activator of transcription 3 inhibitors: a patent review

By Page Brent DG   Ball Daniel P   Gunning Patrick T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 65-83

Informa Healthcare

Access to resources Recommend Favorite

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors

By Mankan Arun K   Greten Florian R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1263-1275

Informa Healthcare

Access to resources Recommend Favorite

Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature

By Lavecchia Antonio   Di Giovanni Carmen   Cerchia Carmen  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 383-400

Informa Healthcare

Access to resources Recommend Favorite

Increased Signal Transducer and Activator of Transcription 3 (STAT3) and Decreased Cyclin D1 in Recurrent Astrocytic Tumours Compared with Paired Primary Astrocytic Tumours

By Zhang K   Pang B   Xin T   Hou X   Jia J   Feng B   Meng L   Xu S   Pang Q  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2103-2109

Field House Publishing

Access to resources Recommend Favorite

Natural products and their derivatives regulating the janus kinase/signal transducer and activator of transcription pathway

By Lin Yuan   Wang Fei   Zhang Guo-Lin  

Journal of Asian Natural Products Research, Vol. 16, Iss. 7, 2014-07 ,pp. : 800-812

Taylor & Francis Ltd

Access to resources Recommend Favorite